Merck KGaA Company Profile (FRA:MRK)

About Merck KGaA

Merck KGaA logo.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: FRA
  • Symbol: MRK
  • CUSIP:
Key Metrics:
  • Previous Close: $98.06
  • 50 Day Moving Average: $96.511
  • 200 Day Moving Average: $87.891
  • Trailing P/E Ratio: 30.683
  • P/E Growth: 0.000
  • Market Cap: $42.64B
Additional Links:
Companies Related to Merck KGaA:

Analyst Ratings

Consensus Ratings for Merck KGaA (FRA:MRK) (?)
Ratings Breakdown: 1 Sell Rating, 11 Hold Ratings, 11 Buy Ratings
Consensus Rating:Hold (Score: 2.43)
Consensus Price Target: €100.55

Analysts' Ratings History for Merck KGaA (FRA:MRK)
DateFirmActionRatingPrice TargetDetails
9/20/2016Berenberg BankSet Price TargetNeutral€101.00View Rating Details
9/8/2016Bank of America Corp.Set Price TargetBuy€115.00View Rating Details
8/30/2016Commerzbank AGSet Price TargetBuy€101.00View Rating Details
8/8/2016BNP ParibasSet Price TargetBuy€114.00View Rating Details
8/5/2016DZ Bank AGReiterated RatingBuyView Rating Details
8/5/2016Nord/LBSet Price TargetBuy€112.00View Rating Details
8/5/2016Credit Suisse Group AGSet Price TargetBuy€108.00View Rating Details
8/5/2016Baader BankSet Price TargetNeutral€97.00View Rating Details
8/5/2016Societe GeneraleSet Price TargetNeutral€97.00View Rating Details
8/4/2016S&P Global Inc.Set Price TargetNeutral€103.00View Rating Details
8/4/2016Independent Research GmbHSet Price TargetNeutral€102.00View Rating Details
8/4/2016equinet AGSet Price TargetBuy€85.00View Rating Details
8/4/2016Warburg ResearchSet Price TargetBuy€103.10View Rating Details
8/2/2016Bankhaus LampeSet Price TargetBuy€112.00View Rating Details
8/1/2016Morgan StanleySet Price TargetNeutral€103.00View Rating Details
7/28/2016Deutsche Bank AGSet Price TargetBuy€110.00View Rating Details
7/26/2016Citigroup Inc.Set Price TargetBuy€115.00View Rating Details
7/21/2016JPMorgan Chase & Co.Reiterated RatingNeutralView Rating Details
5/10/2016Barclays PLCSet Price TargetNeutral€87.00View Rating Details
4/28/2016Goldman Sachs Group Inc.Set Price TargetNeutral€91.00View Rating Details
3/9/2016HSBCSet Price TargetNeutral€88.00View Rating Details
12/11/2015S&P Equity ResearchSet Price TargetNeutral€104.00View Rating Details
12/7/2015Kepler Capital MarketsSet Price TargetSell€75.00View Rating Details
(Data available from 9/25/2014 forward)


Earnings History for Merck KGaA (FRA:MRK)
No earnings announcements for this company have been tracked by


Earnings Estimates for Merck KGaA (FRA:MRK)
No earnings estimates for this company have been tracked by


Dividend History for Merck KGaA (FRA:MRK)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Merck KGaA (FRA:MRK)
No insider trades for this company have been tracked by


Latest Headlines for Merck KGaA (FRA:MRK)
DateHeadline logoGermany stocks mixed at close of trade; DAX up 0.19% (FRA:MRK) - September 22 at 11:02 AM logoEU court says Lundbeck pay-for-delay deals anti-competitive (FRA:MRK) - September 9 at 10:55 AM logoSyndax Pharmaceuticals: A Potential Bio Run-Up Play For 2017 (FRA:MRK) - September 1 at 9:23 AM logoHow Much Medivation Can Really Fetch in a Buyout (FRA:MRK) - August 30 at 9:36 AM logoTraders Likely to Wait and Watch Amid Strong Data (FRA:MRK) - August 27 at 10:37 AM logoMylan offers discounts on EpiPen amid wave of criticism (FRA:MRK) - August 25 at 6:13 PM
News IconUPDATED: Pfizer buys Medivation for $81.50 a share (FRA:MRK) - August 22 at 10:51 AM logoShares fall after trial fail for Juniper Pharmaceuticals (FRA:MRK) - August 19 at 6:12 PM logoEuropean stocks mostly lower with eyes on Fed minutes; DAX down 0.27% (FRA:MRK) - August 17 at 9:22 AM logoRemicade Is Driving Down Merck’s Immunology Franchise (FRA:MRK) - August 16 at 6:24 PM logoGermany stocks mixed at close of trade; DAX down 0.07% (FRA:MRK) - August 1 at 6:03 PM
News IconAfter PhIII disaster, NewLink Genetics plots reorganization (FRA:MRK) - July 29 at 6:25 PM logoMerck’s 2Q16 Estimates: Expect Operational Growth in Revenues (FRA:MRK) - July 27 at 9:12 AM logoWhat to Expect from Merck’s 2Q16 Earnings (FRA:MRK) - July 27 at 6:47 AM logoGermany stocks higher at close of trade; DAX up 0.50% (FRA:MRK) - July 26 at 9:31 AM logoMerck (MRK) Stock Down, Ebola Vaccine Under 'Accelerated' FDA Review (FRA:MRK) - July 25 at 10:47 AM logoA report released earlier today by Independent Research GmbH about (ETR:MRK) Merck ups the target price to 99EUR (FRA:MRK) - July 24 at 5:50 PM logoBig Pharma eyes Bay Area, Boston expansions as it cuts R&D elsewhere (FRA:MRK) - July 12 at 5:30 PM logoMerck (MRK) Stock Gaining, Cutting Research Jobs (FRA:MRK) - July 12 at 2:59 PM logo[$$] Merck to Cut Research Jobs at Three East-Coast Sites (FRA:MRK) - July 12 at 2:52 PM logoMerck And Premier Join Hands To Prevent Fractures For Osteoporosis Patients (FRA:MRK) - June 30 at 10:32 AM logoGilead Sciences: Dominating (FRA:MRK) - June 28 at 2:28 PM logoGermany stocks higher at close of trade; DAX up 1.85% (FRA:MRK) - June 23 at 6:43 PM logoGermany stocks higher at close of trade; DAX up 0.92% (FRA:MRK) - June 15 at 6:15 PM
News IconFDA’s Pazdur chides biopharma for falling into an I/O rut (FRA:MRK) - June 14 at 6:01 PM
News IconRegulator says too many drugmakers chasing same cancer strategy (FRA:MRK) - June 10 at 6:30 PM
News IconToo Many Drug Companies Chasing Same Cancer Strategy: FDA (FRA:MRK) - June 10 at 6:30 PM logoGermany stocks lower at close of trade; DAX down 2.52% (FRA:MRK) - June 10 at 6:30 PM
News IconMerck KGaA (MRK) Given a €99.00 Price Target at Berenberg Bank (FRA:MRK) - June 1 at 6:43 PM
News IconMerck KGaA (MRK) Given a €99.00 Price Target by Berenberg Bank Analysts (FRA:MRK) - June 1 at 6:43 PM logoCancer Immunotherapies Take Center Stage in Pre-ASCO Abstract Releases - Motley Fool (FRA:MRK) - May 27 at 2:44 PM logoMerck Expands Production Know-how to Deliver Full End-To-End Solution for Biopharma Industry (FRA:MRK) - May 2 at 8:10 AM logoMerck Accelerator goes global with launch in Africa (FRA:MRK) - January 28 at 6:11 AM logoMerck Announces New Biopharma Heads for North America and China (FRA:MRK) - January 27 at 7:34 AM logoMerck CEO rules out major acquisitions in 2016 (FRA:MRK) - January 21 at 12:06 PM logoMerck and BrandWatch Technologies Form Long-Term Partnership (FRA:MRK) - January 21 at 4:05 AM logoMerck launches Vivera in Latin America (FRA:MRK) - January 20 at 4:05 AM logoMerck Appoints New Executive Board Members (FRA:MRK) - January 19 at 2:05 AM
News IconIt's Merck vs. Merck as name confusion, complicated by social media, leads to legal showdown (FRA:MRK) - January 17 at 6:45 PM logoUpdated Digital Version of Periodic Table of the Elements (FRA:MRK) - January 4 at 4:08 AM logoMerck and Pfizer Advance Clinical Development Program with Two Additional Phase III Trials of Avelumab (FRA:MRK) - December 22 at 8:10 AM logoRonastar® Lapis Jewel – For Sparkling Deep Blue Cosmetics (FRA:MRK) - December 21 at 4:07 AM logoMerck Acquires Ormet Circuits (FRA:MRK) - December 14 at 4:26 AM logoMerck Confident for 2016 (FRA:MRK) - December 10 at 4:11 AM logoMerck and Pfizer Initiate Two Phase III Studies of Investigational Immunotherapy Avelumab in Advanced Gastric and Gastro-esophageal Junction Cancers (FRA:MRK) - December 9 at 11:09 AM logoMiraval® Cosmic Bronze – The Second Effect Pigment in the New Product Series from Merck (FRA:MRK) - November 30 at 4:06 AM logoGray Modules: New Dimension in Organic Photovoltaics for Buildings (FRA:MRK) - November 26 at 1:06 AM logoMerck and Pfizer Receive Positive Opinion for Orphan Drug Designation for Avelumab in Merkel Cell Carcinoma from EMA Committee for Orphan Medicinal Products (FRA:MRK) - November 25 at 4:15 AM logoMerck Counts on Africa for Growth (FRA:MRK) - November 20 at 2:08 AM logoMerck and the University of Cape Town to Develop a Drug Discovery Platform for Malaria (FRA:MRK) - November 19 at 8:08 AM


Last Updated on 9/25/2016 by Staff